[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE449177T1 - Staphylococcus epidermidis antigene - Google Patents

Staphylococcus epidermidis antigene

Info

Publication number
ATE449177T1
ATE449177T1 AT04724557T AT04724557T ATE449177T1 AT E449177 T1 ATE449177 T1 AT E449177T1 AT 04724557 T AT04724557 T AT 04724557T AT 04724557 T AT04724557 T AT 04724557T AT E449177 T1 ATE449177 T1 AT E449177T1
Authority
AT
Austria
Prior art keywords
antigens
staphylococcus epidermidis
epidermidis antigens
hyperimmune serum
serum reactive
Prior art date
Application number
AT04724557T
Other languages
English (en)
Inventor
Andreas Meinke
Bui Duc Min
Eszter Nagy
Original Assignee
Intercell Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercell Ag filed Critical Intercell Ag
Application granted granted Critical
Publication of ATE449177T1 publication Critical patent/ATE449177T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AT04724557T 2003-03-31 2004-03-31 Staphylococcus epidermidis antigene ATE449177T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03450078 2003-03-31
PCT/EP2004/003398 WO2004087746A2 (en) 2003-03-31 2004-03-31 Staphylococcus epidermidis antigens

Publications (1)

Publication Number Publication Date
ATE449177T1 true ATE449177T1 (de) 2009-12-15

Family

ID=33104246

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04724557T ATE449177T1 (de) 2003-03-31 2004-03-31 Staphylococcus epidermidis antigene

Country Status (8)

Country Link
US (4) US7628994B2 (de)
EP (2) EP2182065A3 (de)
JP (1) JP2007523609A (de)
AT (1) ATE449177T1 (de)
AU (1) AU2004226262A1 (de)
CA (1) CA2520868A1 (de)
DE (1) DE602004024179D1 (de)
WO (1) WO2004087746A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE449177T1 (de) 2003-03-31 2009-12-15 Intercell Ag Staphylococcus epidermidis antigene
DE602004031836D1 (de) * 2003-07-08 2011-04-28 Umc Utrecht Holding Bv Therapeutische verwendung von lpi, einem inhibitor des lectinwegs in staphylokokken bei entzündungskrankheiten
WO2007001423A2 (en) * 2004-10-21 2007-01-04 Wyeth Immunogenic compositions of staphylococcus epidermidis polypeptide and polynucleotide antigens
MX2007015758A (es) * 2005-06-13 2008-02-22 Nabi Biopharmaceuticals Uso de leucocidina de panton-valentine para tratar y prevenir infecciones por estafilococos.
AU2008251982A1 (en) 2007-01-24 2008-11-20 Merck Sharp & Dohme Corp. Polypeptides for inducing a protective immune response against Staphylococcus epidermidis
EP1980269A1 (de) * 2007-04-13 2008-10-15 Katholieke Universiteit Leuven Prävention von Staphylokokken-Biofilmbildung
AR078601A1 (es) 2009-06-22 2011-11-23 Wyeth Llc Composiciones inmunogenicas de antigenos de staphylococcus aureus
WO2013184900A2 (en) * 2012-06-06 2013-12-12 Sanofi Pasteur Biologics, Llc Immunogenic compositions and related methods
ITNA20120046A1 (it) 2012-08-02 2014-02-03 No Self S R L Uso di acidi nucleici di sistemi biologici parassiti, patogeni e infestanti per l'inibizione e/o controllo degli stessi sistemi
NL2022581B1 (en) * 2019-02-14 2020-08-27 Koppert Bv Composition comprising a mixture of dna molecules, uses thereof as biological inhibitor and method for production

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
EP1695978A1 (de) 1990-06-11 2006-08-30 Gilead Sciences, Inc. Nukleinsäureliganden
JP3468773B2 (ja) 1994-07-15 2003-11-17 ザ ユニバーシティ オブ アイオワ リサーチ ファウンデーション 免疫調節オリゴヌクレオチド
RS50101B (sr) 1996-02-24 2009-01-22 Boehringer Ingelheim International Gmbh., Farmaceutski preparati za imunomodulaciju
JP2001504448A (ja) 1996-08-30 2001-04-03 フュルステ，イェンス，ペーター 核酸の鏡面対称選択および進化
US5849902A (en) 1996-09-26 1998-12-15 Oligos Etc. Inc. Three component chimeric antisense oligonucleotides
US5989912A (en) 1996-11-21 1999-11-23 Oligos Etc. Inc. Three component chimeric antisense oligonucleotides
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
DE19742706B4 (de) 1997-09-26 2013-07-25 Pieris Proteolab Ag Lipocalinmuteine
DE19803453A1 (de) 1998-01-30 1999-08-12 Boehringer Ingelheim Int Vakzine
AT408721B (de) 1999-10-01 2002-02-25 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung enthaltend ein antigen
DK2275553T3 (en) * 1999-10-29 2015-08-03 Novartis Vaccines & Diagnostic Neisserial antigenic peptides
AU1478301A (en) * 1999-11-09 2001-06-06 Glaxo Group Limited Staphylococcus epidermidis nucleic acids and proteins
AT409085B (de) 2000-01-28 2002-05-27 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
JP2003531128A (ja) 2000-04-14 2003-10-21 インターツェル・アクチェンゲゼルシャフト 修飾ペプチドを含む医薬調製物
AT410173B (de) 2000-06-08 2003-02-25 Cistem Biotechnologies Gmbh Antigene zusammensetzung
SK287689B6 (sk) 2000-06-08 2011-06-06 Intercell Ag Použitie molekuly oligodeoxynukleovej kyseliny na výrobu imunostimulačnej farmaceutickej kompozície a farmaceutický prípravok
EP1309345A2 (de) 2000-08-17 2003-05-14 Cistem Biotechnologies GmbH Cathelicidine als impfstoffadjuvantien
JP4097178B2 (ja) * 2000-10-03 2008-06-11 株式会社グリーンペプタイド 腫瘍抗原
AT410635B (de) 2000-10-18 2003-06-25 Cistem Biotechnologies Gmbh Vakzin-zusammensetzung
AT410798B (de) * 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
AU2002306849A1 (en) 2001-03-21 2002-10-08 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
AU2002355677A1 (en) * 2001-08-02 2003-02-17 Biosynexus Incorporated Antigenic polypeptides
AU2003274972A1 (en) * 2002-09-13 2004-04-30 Inhibitex, Inc. Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
ATE449177T1 (de) 2003-03-31 2009-12-15 Intercell Ag Staphylococcus epidermidis antigene

Also Published As

Publication number Publication date
AU2004226262A1 (en) 2004-10-14
US8236325B2 (en) 2012-08-07
WO2004087746A3 (en) 2005-04-21
EP1608756B1 (de) 2009-11-18
US7628994B2 (en) 2009-12-08
US8372410B2 (en) 2013-02-12
JP2007523609A (ja) 2007-08-23
US20100297162A1 (en) 2010-11-25
DE602004024179D1 (de) 2009-12-31
US20130122030A1 (en) 2013-05-16
EP2182065A2 (de) 2010-05-05
US20070036778A1 (en) 2007-02-15
WO2004087746A2 (en) 2004-10-14
US20120269843A1 (en) 2012-10-25
EP1608756A2 (de) 2005-12-28
CA2520868A1 (en) 2004-10-14
EP2182065A3 (de) 2010-09-15

Similar Documents

Publication Publication Date Title
ATE441715T1 (de) Streptococcus pyogenes antigene
WO2004092209A3 (en) S. pneumoniae antigens
WO2005103073A3 (en) Td antigens
WO2004099242A3 (en) Streptococcus agalactiae antigens i + ii
ZA200800555B (en) IL-1² binding antibodies and fragments thereof
ATE554107T1 (de) Als therapeutika geeignete monovalente antikörperfragmente
WO2002062850A3 (en) Hybrid antibodies and uses thereof
WO2004044204A3 (fr) Fragments variables d'anticorps de camelides a chaine unique et leurs applications pour le diagnostic et le traitement de pathologies diverses.
IN2009KN02655A (de)
DK1706424T3 (da) FC-region varianter
BRPI0411854A (pt) veìculos protéicos para vacinas
NO20054836L (no) Nogo-reseptorbindingsprotein
WO2002075274A3 (fr) Methode et trousse pour le suivi des maladies neurodegeneratives
WO2004106367A3 (en) Enterococcus antigens
WO2004029072A3 (en) PrPsc -INTERACTING MOLECULES AND USES THEREOF
ATE449177T1 (de) Staphylococcus epidermidis antigene
WO2004094467A3 (en) H. pylori antigens
ATE477274T1 (de) Gegen clostridium difficile gerichtete antikörper
WO2004046314A3 (en) Methods for detecting asymmetric dimethylarginine in a biological sample
WO2001066752A3 (en) Reproduction-specific genes
WO2004113374A3 (en) Chlamydia pneumoniae antigens

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties